Company: CERO
Filing Date: 2025-10-23
Form Type: 424B3
Source: 0001213900-25-101650
Chunk: 5

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-23
Form: 424B3
Chunk 5
---
,000 shares of the Company’s authorized and unissued preferred stock as Series E Preferred Stock (the “Series E Shares”)
and establish the rights, preferences and privileges of the Series E Preferred Stock pursuant to the Certificate of Designations of Rights
and Preferences of the Series E Preferred Stock (the “Certificate of Designations”), to be filed with the Secretary
of State of the State of Delaware, as summarized below:

General. Each share of Series E Preferred
Stock has a stated value of $1,000 per share and, when issued, the Series E Preferred Stock will be fully paid and non-assessable.

Ranking. The Series E Preferred Stock,
with respect to the payment of dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company,
ranks senior to all capital stock of the Company (except the Series A convertible preferred stock which will rank senior to the Series
E Preferred Stock and except for the Series C convertible preferred stock and Series D convertible preferred stock, which will rank pari passu to the Series E Preferred Stock) unless the Required Holders (as defined in the Securities Purchase Agreement) consent to the
creation of other capital stock of the Company that is senior or equal in rank to the Series E Preferred Stock.

Dividends. The holders of Series E Preferred
Stock will be entitled to dividends, on an as-if converted basis, equal to and in the same form as dividends actually paid on shares of
the Company’s common stock, par value $0.0001 per share (the “Common Stock”), when and if actually paid.

Purchase Rights. If at any time the
Company grants, issues or sells any options, convertible securities, or rights to purchase stock, warrants, securities or other
property pro rata to all or substantially all of the record holders of any class of Common Stock (the “Purchase Rights”), then each holder of Series E Preferred Stock will be entitled to acquire, upon the terms applicable to such
Purchase Rights, the aggregate Purchase Rights which such holder could have acquired if such holder had held the number of shares of
Common Stock acquirable upon complete conversion of all the Series E Preferred Stock (without taking into account any limitations or
restrictions on the convertibility of the Series E Preferred Stock and assuming for such purpose that all the Series E Preferred
Stock held by such holder were converted at the Alternate Conversion Price (as defined below) in effect as of the applicable record date); subject to certain limitations on beneficial ownership.

<div align='